All lobbying filings

FEDERAL STREET STRATEGIES, LLC

FEDERAL STREET STRATEGIES, LLC filed a Q3 report for BIOGEN, INC. on October 20, 2026, reporting $50,000 in lobbying income.

Lobbying for BIOGEN, INC. · Biotechnology Company.

All filings by FEDERAL STREET STRATEGIES, LLC · Everything BIOGEN, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 4

KAADE WALLACE New on this filing

Previously held: Legislative Correspondent, U.S. Senator Amy Klobuchar; Staff Assistant, U.S. Representative Betty McCollum
PAUL BRATHWAITE New on this filing

Previously held: Executive Director, Congressional Black Caucus; Deputy Assistant Secretary of Labor, ESA, Department of Labor; Chief of Staff, ESA, Department of Labor; and Special Assistant, U.S. Secretary of Labor, Department of Labor.
VEN NERALLA New on this filing

Previously held: Chief of Staff, U.S. Rep. Andy Levin; Deputy Chief of Staff,U.S. Rep. Pramila Jayapal; Legislative Director, U.S. Rep.Barbara Lee; Legislative Assistant, U.S. Rep. Peter DeFazio;Senior Advisor, USDA; OPP; and MCC.
STACEY LEAVANDOSKY New on this filing

Previously held: Chief of Staff, U.S. Representative Zoe Lofgren; Senior Advisor, Committee on Science, Space & Technology; Senior Advisor, Committee on House Administration; Executive Director, California Democratic Congressional Delegation.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to Alzheimer's Disease and treatment. Amyotrophic lateral sclerosis (ALS), Lou Gehrigs Disease and treatment and Lupus. Issues related to the budget and appropriations process

Medicare/Medicaid

Issues related to rare diseases and treatment. Issues related to Mental Health treatment. Issues related to maternal health. Issues related to the budget and appropriations process

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.